β-carotene downregulates the steady-state and heregulin-α- induced COX-2 pathways in colon cancer cells

Journal of Nutrition

Volumn 135, Issue 1, 2005, Pages 129-136

  Palozza, Paola ^a   Serini, Simona ^a   Maggiano, Nicola ^a   Tringali, Giuseppe ^a   Navarra, Pierluigi ^a   Ranelletti, Franco O ^a   Calviello, Gabriella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Apoptosis; Cell growth; Colon cancer cells; COX 2 expression; carotene

Indexed keywords

BETA CAROTENE; CYCLOOXYGENASE 2 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL; COLON ADENOCARCINOMA; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEADY STATE;

EID: 11844263982     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.1.129     Document Type: Article

References (50)

1. Prescott, S. M. & White, R. L. (1996) Self-promotion? Intimate connections between APC and prastaglandin H synthase-2. Cell 87: 783-786.
2. Tsujii, M. A. & DuBois, R. N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501.
3. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F. & Taketo, M. M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809.
4. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrembach, S. & DuBois, R. N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188.
5. DuBois, R. N., Radhika, A., Reddy, B. S. & Entingh, A. J. (1996) Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262.
6. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. & Hla, T. (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55: 3785-3789.
7. DuBois, R. N., Awad, J., Morrow, J., Roberts, L. J., II & Bishop, P. R. (1994) Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J. Clin. Investig. 93: 493-498.
8. Coffey, R. J., Hawkey, C. J., Damstrup, L., Graves-Deal, R., Daniel, V. C., Dempsey, P. J. Chinery, R., Kirkland, S. C., DuBois, R. N., Jetton, T. L. & Morrow, J. D. (1997) Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Proc. Natl. Acad. Sci. U.S.A. 94: 657-662.
9. Richter, M., Weiss, M., Weinberger, I., Furstenberger, G. & Marian, B. (2001) Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 22: 17-25.
10. Elder, D.J.E. & Paraskeva, C. (1999) Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs. Apoptosis 4: 365-372.
11. Masunaga, R., Kohno, H., Kumar, Dhar, D., Kotoh, T., Tachibana, M., Kubota, H. & Nagasue, N. (2000) Sulindac inhibits growth of rat colon carcinoma by inducing apoptosis. Eur. Surg. Res. 32: 305-309.
12. Elder, D.J.E., Halton, D., Playe, L. C. & Paraskeva, C. (2002) The MEK/ERK pathway mediates Cox-2-selective NSAID-induced apoptosis and induced Cox-2 protein expression in colorectal carcinoma cells. Int. J. Cancer 99: 323-327.
13. Surth, Y.-J. (1999) Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428: 305-327.
14. Giovannucci, E., Stampfer, M. J., Colditz, G., Rimm, E. B. & Willett, W. C. (1992) Relationship of diet to risk of colorectal adenoma in men. J. Natl. Cancer Inst. 84: 91-98.
15. Mayne, S. T. (1996) β-Carotene, carotenoids, and disease prevention in humans, FASEB J. 10: 690-701.
16. Slattery, M. L., Benson, J., Curtin, K., Ma, K.-N., Schaeffer, D. & Potter, J. D. (2000) Carotenoids and colon cancer. Am. J. Clin. Nutr. 71: 575-582.
17. Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., Willet, W. & Peto, R. (1996) Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasm and cardiovascular disease. N. Engl. J. Med. 334: 1145-1149.
18. Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S. & Hammar, S. (1996) Effects of a combination of β-carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334: 1150-1155.
19. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330: 1029-1035.
20. Taylor, P. R., Li, B., Dawsey, S. M., Li, J.-Y., Yang, C. S., Guo, W. & Blot, W. J. (1994) Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Cancer Res. 54: 2029s-2031s.
21. Cahill, R. J., O'Sullivan, K. R., Mathias, P. M., Beattie, S., Hamilton, H. & Morain, C. O. (1993) Effect of vitamin antioxidant supplementation on cell kinetics of patients with adenomatous polyps. Gut 34: 963-967.
22. Tang, G., Shiau, A., Russell, R. M. & Mobarhan, S. (1995) Serum retinoic acid in patients with resected benign and malignant colonic neoplasias on β-carotene supplementation. Nutr. Cancer 23: 291-298.
23. Alabaster, O., Tang, Z., Frost, A. & Shivapurkar, N. (1995) Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16: 127-132.
24. Temple, N. J. & Basu, T. K. (1987) Protective effect of β-carotene against colon tumors in mice. J. Natl. Cancer Inst. 78: 1211-1214.
25. Tanaka, T., Kawamori, T., Ohnishi, M., Makita, H., Mori, H., Satoh, K. & Hara, A. (1995) Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis 16: 2957-2963.
26. Iftikhar, S., Lietz, H., Mobarhan, S. & Frommel, T. O. (1996) In vitro β-carotene toxicity for human colon cancer cells. Nutr. Cancer 25: 221-230.
27. Palozza, P., Calviello, G., Serini, S., Maggiano, N., Lanza, P., Ranelletti, F. O. & Bartoli, G. M. (2001) β-Carotene at high concentrations induces apoptosis by enhancing oxy-radicals production in human adenocarcinoma cells. Free Radic. Biol. Med. 30: 1000-1007.
28. Palozza, P., Serini, S., Torsello, A., Boninsegna, A., Covacci, V., Maggiano, N., Ranelletti, F. O., Wolf, F. I. & Calviello, G. (2002) Regulation of cell cycle progression and apoptosis by β-carotene in undifferentiated and differentiated HL-60 leukemia cells: possible involvement of a redox mechanism. Int. J. Cancer 97: 593-600.
29. Palozza, P., Maggiano, N., Calviello, G., Lanza, P., Piccioni, E., Ranelletti, F. O. & Bartoli, G. M. (1998) Canthaxanthin induces apoptosis in human cancer cell lines. Carcinogenesis 19: 373-376.
30. Palozza, P., Serini, S., Maggiano, N., Angelici, M., Boninsegna, A., Di Nicuolo, F., Ranelletti, F. O. & Calviello, G. (2002) Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23: 11-18.
31. Di Nicuolo, F., Serini, S., Boninsegna, A., Palozza, P. & Calviello, G. (2001) Redox regulation of cell proliferation by pyrrolidine dithiocarbamate in murine thymoma cells transplanted in vivo. Free Radic. Biol. Med. 31: 1424-31.
32. Palozza, P., Serini, S., Torsello, A., Maggiano, N., Ranelletti, F. O., Wolf, F. I. & Calviello, G. (2003) Mechanism of activation of caspase cascade during beta-carotene-induced apoptosis in human tumor cells. Nutr. Cancer 47: 76-87.
33. Vairano, M., Dello Russo, C., Bozzoli, G., Battaglia, A., Scambia, G., Trincali, G., Aloe-Spiriti, M. A., Preziosi, P. & Navarra, P. (2002) Erythropoietin exerts antiapoptotic effects on rat microglial cells in vitro. Eur. J. Neurosci. 16: 684-692.
34. Vadlamudi, R., Mandal, M., Adam, L., Steinbach, G., Mendelsohn, J. & Kumar, R. (1999) Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene 18: 305-314.
35. Cho, H. J., Kim, W. K., Kim, E. J., Jung, K. C., Park, S., Lee, H. S., Tyner, A. L. & Park, J. H. (2003) Conjugated linoleic acid inhibits cell proliferation and Erb3 signaling in HT-29 human colon cell line. Am. J. Physiol. 284: G996-G1005.
36. Stove, C., Stove, V., Derycke, L., Van Marck, V., Mareel, M. & Bracke, M. (2003) The heregulin/human epidermal growth factor receptor as a growth factor system in melanoma with multiple ways of deregulation. J. Investig. Dermatol. 121: 802-812.
37. Hume, C. R., Kirkegaard, M. & Oesterle, E. C. (2003) ErbB expression: the mouse inner ear and maturation of the mitogenic response to heregulin. J. Assoc. Res. Otolaryngol. 4: 422-443.
38. Anido, J., Matar, P., Albanell, J., Guzman, M., Rojo, F., Arribas, J., Averbuch, S. & Baselga, J. (2003) ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. Clin. Cancer Res. 9: 1274-1283.
39. Venkateswarlu, S., Dawson, D. M., St Clair, P., Gupta, A., Willson, J. K. & Brattain, M. G. (2002) Autocrine heregulin generates growth factor independence and blocks apoptosis in colon cancer cells. Oncogene 21: 78-86.
40. Agarwal, B., Swaroop, P., Protiva, P., Raj, S. V., Shrin, H. & Holt, P. R. (2003) Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells. Apoptosis 8: 649-654.
41. Totzke, G., Schulze-Osthoff, K. & Janicke, R. U. (2003) Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of Cox-2 inhibition. Oncogene 22: 8021-8030.
42. Cook, N. R., Stampfer, M. J., Ma, J., Manson, J. E., Sacks, F. M., Buring, J. & Hennekens, C. H. (1999) Beta-carotene supplementation for patients with low baseline levels and decreased risk of total and prostate carcinoma. Cancer 86: 1783-1792.
43. Prince, M. R. & Frisoli, J. K. (1993) Beta-carotene accumulation in serum and skin. Am. J. Clin. Nutr. 57: 175-181.
44. Xie, W. & Herschman, H. R. (1996) Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J. Biol. Chem. 271: 31742-31748.
45. Adderley, S. R. & Fitzgerald, D. J. (1999) Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J. Biol. Chem. 274: 5038-5046.
46. Prasad, K. S. & Brandt, S. J. (1997) Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein. J. Biol. Chem. 272: 11457-11462.
47. Davis, S., Vanhoutte, P., Pages, C., Caboche, J. & Laroche, S. (2000) The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo. J. Neurosci. 20: 4563-4572.
48. Park, J.-W., Choi, Y. J., Suh, S.-I. & Kwon, T. K. (2001) Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells. Biochem. Biophys. Res. Commun. 286: 721-725.
49. Palozza, P., Serini, S., Di Nicuolo, F., Boninsegna, A., Torsello, A., Maggiano, N., Ranelletti, F. O., Wolf, F. I., Calviello, G. & Cittadini, A. (2004) β-Carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensate. Carcinogenesis 25: 1-11.
50. Vanem, J. R., Bakhle, Y. S. & Botting, R. M. (1998) Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38: 97-120.